Antimicrobial resistance and its impact on cancer care
Antimicrobial resistance (AMR) or drug resistance, including antibiotic resistance, is a growing public health issue and needs urgent attention in countries around the world. Due to a variety of factors, people with cancer are particularly vulnerable to AMR, which is threatening the progress being made in cancer care.
New report: Drug-resistant infections will kill more people than cancer by 2050 - Vox
Possible reasons for the increasing antimicrobial resistance in
Baxter Italia su LinkedIn: #worldsepsisday #sepsisprevention #sepsis #connectingcare #podcast…
What is antimicrobial resistance and why do we need to take action against it? – UK Health Security Agency
Cancer, Antimicrobial Resistance and Health Emergencies Highlighted by IAEA at WHO Meeting
Frontiers Probiotics in Cancer
Huseyin Orun on LinkedIn: #uicc #cancer #podcast
Baxter France on LinkedIn: Plus d'expérience avec ICNET
Baxter Italia on LinkedIn: #makingameaningfuldifference
Antimicrobial resistance and its impact on cancer care